Biocatalytic production of (S)-2-aminobutanamide by a novel D-aminopeptidase from Brucella sp with high activity and enantioselectivity

被引:10
作者
Tang, Xiao-Ling [1 ,2 ]
Lu, Xia-Feng [1 ,2 ]
Wu, Zhe-Ming [1 ,2 ]
Zheng, Ren-Chao [1 ,2 ]
Zheng, Yu-Guo [1 ,2 ]
机构
[1] Zhejiang Univ Technol, Coll Biotechnol & Bioengn, Key Lab Bioorgan Synth Zhejiang Prov, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang Univ Technol, Minist Educ, Engn Res Ctr Bioconvers & Biopurificat, Hangzhou 310014, Zhejiang, Peoples R China
关键词
D-Aminopeptidase; Kinetic resolution; (S)-2-aminobutanamide; Levetiracetam; DYNAMIC KINETIC RESOLUTION; EPSILON-CAPROLACTAM RACEMASE; OCHROBACTRUM-ANTHROPI; LEVETIRACETAM; PROTEINS; PROFILE;
D O I
10.1016/j.jbiotec.2017.12.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
As the important chiral building block of levetiracetam, the synthesis of (S)-2-aminobutanamide has attracted a great deal of attention. The D-aminopeptidase catalyzed kinetic resolution of 2-aminobutanamide was demonstrated as an effective strategy for (S)-2-aminobutanamide production. In this study, a novel D-aminopeptidase from Brucella sp. (Bs-Dap) was screened and systematically characterized. The enzyme exhibited maximum activity at 45 degrees C, pH 8.0 and it showed relatively low Km value toward 2-aminobutanamide, indicating its high affinity to the substrate. Kinetic resolution of 300 g/L 2-aminobutanamide by recombinant Escherichia coli whole cells (4 g/L wet cell weight) resulted in 50% conversion and >99% e.e. within 80 min. The catalytic properties of Bs-Dap demonstrated its great potential for industrial production of (S)-2-aminobutanamide.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 25 条
[1]   Dynamic kinetic resolution of amino acid amide catalyzed by D-aminopeptidase and α-amino-ε-caprolactam racemase [J].
Asano, Y ;
Yamaguchi, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (21) :7696-7697
[2]  
ASANO Y, 1989, J BIOL CHEM, V264, P14233
[3]  
Asano Y., 2015, RECL TRAV CHIM PAY B, V110, P206
[4]  
Boesten W. H. J., 2012, Eur. Pat. Appl, Patent No. [EP 2524910, 2524910]
[5]   Cell adaptation to solvent, substrate and product: a successful strategy to overcome product inhibition in a bioconversion system [J].
de Carvalho, CCCR ;
Poretti, A ;
da Fonseca, MMR .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2005, 69 (03) :268-275
[6]   Levetiracetam: Part II, the clinical profile of a novel anticonvulsant drug [J].
De Smedt, Tim ;
Raedt, Robrecht ;
Vonck, Kristl ;
Boon, Paul .
CNS DRUG REVIEWS, 2007, 13 (01) :57-78
[7]   Improved racemate resolution of pentan-2-ol and trans-(Z)-cyclooct-5-ene-1,2-diol by lipase catalysis [J].
Graber, Marianne ;
Rouillard, Herve ;
Delatouche, Regis ;
Fniter, Najla ;
Belkhiria, Belsem ;
Bonnet, Antoine ;
Domon, Lisianne ;
Thiery, Valerie .
JOURNAL OF BIOTECHNOLOGY, 2016, 238 :60-68
[8]   A theoretical study on the activation of Ser70 in the acylation mechanism of cephalosporin antibiotics [J].
Ke, YY ;
Lin, TH .
BIOPHYSICAL CHEMISTRY, 2005, 114 (2-3) :103-113
[9]   Bioinformatic Analysis, Molecular Modeling of Role of Lys65 Residue in Catalytic Triad of D-aminopeptidase from Ochrobactrum anthropi [J].
Khaliullin, I. G. ;
Suplatov, D. A. ;
Shalaeva, D. N. ;
Otsuka, M. ;
Asano, Y. ;
Svedas, V. K. .
ACTA NATURAE, 2010, 2 (02) :66-70
[10]   Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy [J].
Klitgaard, H ;
Matagne, A ;
Gobert, J ;
Wülfert, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (2-3) :191-206